Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections

New England Journal of Medicine

Volumn 346, Issue 24, 2002, Pages 1871-1877

  Perl, Trish M ^a,d,e   Cullen, Joseph J ^a   Wenzel, Richard P ^a   Zimmerman, M Bridget ^a   Pfaller, Michael A ^a   Sheppard, Deborah ^a   Twombley, Jennifer ^a   French, Pamela P ^a,c   Herwaldt, Loreen A ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c GLAXOSMITHKLINE   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PSEUDOMONIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GENERAL SURGERY; GYNECOLOGIC SURGERY; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; NEUROSURGERY; NOSE; OINTMENT; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; THORAX SURGERY; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CROSS INFECTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MUPIROCIN; NOSE; OINTMENTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION;

EID: 0037071793     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa003069     Document Type: Article

References (35)

1. Nosocomial infections in surgical patients in the United States, January 1986-June 1992
2. An overview of nosocomial infections, including the role of the microbiology laboratory
3. Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery
4. Postoperative wound infection: A controlled study of the increased duration of hospital stay and direct cost of hospitalization
5. The economic implications of infection in cardiac surgery
6. The impact of surgical-site infections in the 1990s: Attributable mortality, excess length of hospitalization, and extra costs
7. New approaches to reduce Staphylococcus aureus nosocomial infection rates: Treating S. aureus nasal carriage
8. Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks
9. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection
10. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment
11. Elimination of Staphylococcus aureus nasal carriage in health care workers: Analysis of six clinical trials with calcium mupirocin ointment
12. The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: An analysis of cost-effectiveness
13. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients
14. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: A decision analysis
15. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients
16. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus
17. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics
18. Prophylactic mupirocin could reduce orthopedic wound infections: 1,044 Patients treated with mupirocin compared with 1,260 historical controls
19. Nosocomial infections: Validation of surveillance and computer modeling to identify patients at risk
20. Restriction endonuclease analysis of plasmid DNA from methicillin-resistant Staphylococcus aureus: Clinical application over a three-year period
21. CDC definitions for nosocomial infections, 1988
22. Gram-negative bacteremia. II. Clinical, laboratory, and therapeutic observations
23. The Karnofsky Performance Status Scale: An examination of its reliability and validity in a research setting
24. Surgical wound infection rates by wound class, operative procedure, and patient risk index: National Nosocomial Infections Surveillance System
25. Interpretive criteria for testing susceptibility of staphylococci to mupirocin
26. How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: A review for healthcare epidemiologists
27. Head-injured patients who are nasal carriers of Staphylococcus aureus are at high risk for Staphylococcus aureus pneumonia
28. Nasal colonization with methicillin-resistant Staphylococcus aureus on admission to the surgical intensive care unit increases the risk of infection
29. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains
30. Nasal carriage as a source of Staphylococcus aureus bacteremia
31. Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery
32. The role of Staphylococcus aureus carriage in saphenous vein harvest site surgical wound infections